Stock listing
M1RN34 Stock Price, News, Filings & Events — Moderna, Inc.
Selected listing: M1RN34 · BMFBOVESPA · BRL · BR
This page tracks Moderna, Inc.'s M1RN34:BMFBOVESPA listing on BMFBOVESPA in BRL for BR, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following M1RN34:BMFBOVESPA. M1RN34:BMFBOVESPA is the stock-level entry point for investors researching Moderna, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- M1RN34:BMFBOVESPA
- Asset type
- Stock
- Market cap
- $55.09B
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- BMFBOVESPA
- Currency
- BRL
Moderna, Inc. M1RN34:BMFBOVESPA stock context
This page tracks Moderna, Inc.'s M1RN34:BMFBOVESPA listing on BMFBOVESPA in BRL for BR, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following M1RN34:BMFBOVESPA. M1RN34:BMFBOVESPA is the stock-level entry point for investors researching Moderna, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Moderna, Inc.
Moderna Announces Pricing of Upsized $2.6 Billion Offering of Convertible Senior Notes
August 28, 2026
Moderna Receives U.S. FDA Approval for Updated 2026-2027 COVID-19 Vaccines
August 27, 2026
Moderna Announces Proposed Private Placement of $2.0 Billion of Convertible Senior Notes
August 27, 2026
Moderna Receives U.S. FDA Approval for Influenza Vaccine mFLUSIVA
August 5, 2026
Moderna Announces Initiation of Phase 1 Clinical Trial of mRNA-1469, Moderna's Investigational Vaccine Against Bundibugyo Ebolavirus
August 4, 2026
Moderna, Inc. earnings calls
Moderna, Inc. (MRNA) Q2 2026 Earnings Call
July 31, 2026 · Replay with transcript and chapters
Moderna, Inc. (MRNA) Q1 2026 Earnings Call
May 1, 2026 · Replay with transcript and chapters
Moderna, Inc. (MRNA) Q4 2025 Earnings Call
February 13, 2026 · Replay with transcript and chapters
Moderna, Inc. (MRNA) Q3 2025 Earnings Call
November 6, 2025 · Replay with transcript and chapters
Moderna, Inc. (MRNA) Q2 2025 Earnings Call
August 1, 2025 · Replay with transcript and chapters
Moderna, Inc. (MRNA) Q1 2025 Earnings Call
May 1, 2025 · Replay with transcript and chapters
Research Moderna, Inc.
Moderna, Inc. investor report
Review AI stock analysis and investor report context for M1RN34:BMFBOVESPA.
Moderna, Inc. company profile
View the public company page for Moderna, Inc. on 6ix.
Moderna, Inc. news
Read company news and market updates connected to Moderna, Inc..
Moderna, Inc. investor events
Find investor webinars, events, and replay context for Moderna, Inc..
Alternate listings
MRNA:NASDAQ
US · USD
Alternate listing for Moderna, Inc.; the primary context on this page is M1RN34:BMFBOVESPA.
0QF:GETTEX
DE · EUR
Alternate listing for Moderna, Inc.; the primary context on this page is M1RN34:BMFBOVESPA.
1MRNA:MIL
IT · EUR
Alternate listing for Moderna, Inc.; the primary context on this page is M1RN34:BMFBOVESPA.
0QF:XETR
DE · EUR
Alternate listing for Moderna, Inc.; the primary context on this page is M1RN34:BMFBOVESPA.
0QF:TRADEGATE
DE · EUR
Alternate listing for Moderna, Inc.; the primary context on this page is M1RN34:BMFBOVESPA.
MRNA:BCBA
AR · ARS
Alternate listing for Moderna, Inc.; the primary context on this page is M1RN34:BMFBOVESPA.
A2N9D9:LSX
DE · EUR
Alternate listing for Moderna, Inc.; the primary context on this page is M1RN34:BMFBOVESPA.
MRNA:BMV
MX · MXN
Alternate listing for Moderna, Inc.; the primary context on this page is M1RN34:BMFBOVESPA.
MRNA:BOATS
US · USD
Alternate listing for Moderna, Inc.; the primary context on this page is M1RN34:BMFBOVESPA.
4MRNA:EUROTLX
IT · EUR
Alternate listing for Moderna, Inc.; the primary context on this page is M1RN34:BMFBOVESPA.
A2N9D9:LS
DE · EUR
Alternate listing for Moderna, Inc.; the primary context on this page is M1RN34:BMFBOVESPA.
0A45:LSIN
GB · USD
Alternate listing for Moderna, Inc.; the primary context on this page is M1RN34:BMFBOVESPA.